Paul Calabresi Clinical Oncology K12 Program
This NIH-NCI funded program combines key didactic, research, and career development components to train independent and productive clinical oncology researchers. The curriculum is guided by two research tracks in Basic/Translational and Clinical science. Scholars participate in four training components: (1) core competencies, (2) advanced coursework, (3) career development, and (4) mentored research. The mentored research training plan will be supervised by two senior, independently funded faculty members (one Basic/Translational mentor and one Clinical mentor) who will guide the scholar in the development and conduct of his/her research project. Scholars are expected to have developed their own investigator-initiated clinical trial during the training period, and have plans to secure suitable funding to support it.
The goal of the program is to train junior faculty (basic-translational scientists and clinician scientists) as investigators in team-based patient-oriented cancer research. Upon successful completion of a three-year, salary-supported core curriculum, scholars will receive a UC Davis Comprehensive Cancer Center Certificate in Clinical Cancer Research.
September 7, 2021
Chengfei Liu Receives R37 National Cancer Institute (NCI) Award
Chengfei Liu has received a $2 million R37 National Cancer Institute (NCI) award for prostate cancer research. Dr. Liu is the first early-stage cancer investigator at UC Davis to receive an R37 award. Dr. Liu was a dean’s scholar in the UC Davis Paul Calabresi Career Development K12 program, which was of immense importance in his trajectory toward the R37. K12 program director and Comprehensive Cancer Center Director, Dr. Primo Lara said, “This award will help him further develop his career and his research, while making important contributions to our understanding of what’s driving resistant prostate cancer.”